It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
FDA inspectors cited Novartis’ plant for a dozen quality control problems last summer, in a report posted to the agency’s website. Company officials failed to properly investigate 166 complaints of mixed-up pills found in Novartis bottles since 2009, according to inspectors. The inspectors also concluded that none of the 223 customer complaints received by the plant last year were adequately reviewed, according to the report.